Our latest paper
Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study
JMIR 2020;22(12):e24048
In this study that included a large number of sites (66) and patient encounters (~200,000), Biocogniv leveraged its ROCfinder™ platform to discover a model that can discriminate COVID-19 using only routine blood tests (CBC, CMP), and that generalizes well to hospitals (23) other than the ones it was trained on (43).